Agios Pharmaceuticals, Inc.
(NASDAQ : AGIO)

( )
AGIO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.90%168.391.3%$496.78m
BIIBBiogen Inc.
0.65%230.761.3%$480.84m
CELGCelgene Corporation
-0.62%94.831.3%$471.13m
GILDGilead Sciences, Inc.
-0.75%65.860.9%$453.88m
ILMNIllumina, Inc.
-2.29%300.593.5%$305.96m
REGNRegeneron Pharmaceuticals, Inc.
-0.78%302.572.6%$276.84m
AAgilent Technologies, Inc.
-0.29%68.911.6%$198.64m
VRTXVertex Pharmaceuticals Incorporated
-1.78%165.731.9%$176.80m
EXASExact Sciences Corporation
-0.16%96.0425.3%$171.72m
ALXNAlexion Pharmaceuticals, Inc.
-2.80%127.232.0%$150.06m
BMRNBioMarin Pharmaceutical Inc.
-2.31%86.664.3%$118.53m
SRPTSarepta Therapeutics, Inc.
-3.37%117.5714.7%$114.20m
INCYIncyte Corporation
-0.48%76.832.5%$105.26m
IONSIonis Pharmaceuticals, Inc.
0.09%67.468.2%$98.12m
ALNYAlnylam Pharmaceuticals, Inc
-2.49%65.869.2%$93.34m

Company Profile

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.